Fundz

Gleamer acquires Pixyl and Caerus Medical

RECENTLY ACQUIREDMar 11, 2025

Acquiring Company

Gleamer SAS

Acquired Company

Pixyl

ParisParisBiotechnologyHealth CareArtificial IntelligenceMedical DeviceImage RecognitionBiotechnologyHealth CareMedicalMedical Device

Description

Gleamer has acquired Pixyl and Caerus Medical, enhancing its AI-powered MRI capabilities. This acquisition adds MRI solutions to Gleamer's existing portfolio of radiology applications. Financial details were not disclosed, but the move will increase Gleamer's workforce to over 100 employees across seven countries.

Quick answer

Gleamer SAS is acquiring Pixyl, announced March 11, 2025. Gleamer SAS is based in Paris, Ile-de-France, France.

How much did Gleamer SAS pay for Pixyl?
The deal value was not disclosed.
What does Gleamer SAS do?
Gleamer SAS is a leading radiology AI company known for its cloud-first solutions.
Where are Gleamer SAS and Pixyl based?
Gleamer SAS is based in Paris, Ile-de-France, France. Pixyl is based in Paris, Ile-de-France, France.
Who are the decision-makers at Gleamer SAS?
Fundz holds 1 contact at Gleamer SAS. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Medical Device and Image Recognition

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Gleamer SAS, and when

When Gleamer SAS changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Gleamer SAS raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gleamer SAS, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gleamer SAS. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gleamer SAS

Location

Paris, Ile-de-France, France

About

Gleamer SAS is a leading radiology AI company known for its cloud-first solutions. They provide a broad portfolio of FDA-cleared and CE-marked AI solutions for various radiological applications. The company serves a wide array of healthcare systems and imaging centers worldwide. Gleamer has achieved rapid growth with a strong annual recurring revenue model.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gleamer SAS makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Christian
Likely contact at this company
••••••••@••••••••

See Christian's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Gleamer SAS's next move

Learn about Strategic plan

Frequently asked

Who acquired Pixyl?

Pixyl was acquired by Gleamer SAS, based in Paris. The deal was reported on March 11, 2025. Gleamer SAS is a leading radiology AI company known for its cloud-first solutions. They provide a broad portfolio of FDA-cleared and CE-marked AI solutions for various radiological applications. Gleamer SAS is privately held and operates in Biotechnology.

When did Gleamer SAS acquire Pixyl?

Gleamer SAS's acquisition of Pixyl was reported on March 11, 2025. Gleamer has acquired Pixyl and Caerus Medical, enhancing its AI-powered MRI capabilities. This acquisition adds MRI solutions to Gleamer's existing portfolio of radiology applications. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Pixyl do?

Pixyl is the developer of Pixyl.Neuro, a CE-marked medical device cleared by the FDA for early detection of neurodegenerative conditions. Their technology focuses on improving outcomes for patients with neuroinflammatory diseases. It is privately held, operating in Biotechnology, and is based in Paris.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.